The Challenge of Change - Managing Excipients Control
Colorcon
06-Jul-2006 - In an incident that state and federal environmental regulators are treating as "serious," Merck released 25 gallons of a cyanide-containing chemical from its West Point facility in Pennsylvania to the sewer, killing hundreds of fish and triggering health advisories.
05-Jul-2006 - Cambrex Bio Science has successfully completed its first monoclonal antibody project in the company's new cell culture bioreactor, as well as its first small-large molecule conjugation project.
05-Jul-2006 - As America desperately waited for its influenza vaccines, Chiron had to deal with major quality control issues between July and October 2005 at its troubled vaccine manufacturing plant in Liverpool according to a US Food and Drug Administration (FDA) inspection report.
04-Jul-2006 - New Brunswick Scientific (NBS) has introduced two new benchtop incubator shakers, the first in a range of eight new models replacing the original C-Line. The shakers have been designed to allow reproducible results all the way down the cell line.
04-Jul-2006 - Sanofi pasteur's vaccine manufacturing plant in Pennsylvania, where half of America's influenza vaccines are made, has been served with a warning letter by the US Food and Drug Administration (FDA), asking for measures to ensure batches of its flu shot ingredients do not become contaminated again.
04-Jul-2006 - New guidelines for the import and manufacture of medical devices in India have now come into effect, aimed at increasing world confidence in medical devices made in the region.
04-Jul-2006 - Best Practices Research and Consulting have put together a toolkit to help pharma companies improve manufacturing quality assurance and efficiency.
04-Jul-2006 - Frost & Sullivan has awarded biopharmaceutical firm Cytogenix with its 2006 award for innovation in biotechnology processing for its cell-free manufacturing method that enables generation of large quantities of high-purity DNA in small highly automated production modules at a fraction of the time and cost of traditional bioprocess methods.
03-Jul-2006 - Shield Medicare, a British supplier of alcohols, disinfectants and consumables to pharmaceutical cleanrooms, has been taken over by US cleaning products provider Ecolab, seeking to capture more of the European market.
03-Jul-2006 - BioPartners has failed to bring its second biosimilar product into Europe after the European Agency for the Evaluation of Medicinal Products (EMEA) issued a negative opinion on its hepatitis C drug, citing characterisation, manufacturing and quality control concerns.
29-Jun-2006 - French purification specialist Novasep has unveiled a new series of preparative high-performance liquid chromatography (HPLC) columns that are ideally suited for the purification of any amount of product.
29-Jun-2006 - Activotec makes available an entry-level Supercritical Fluid Extractor (SFE) to suit routine analytical work in smaller laboratories that might require many features typically found in more costly SFE equipment.
29-Jun-2006 - After launching its flagship oral insulin spray in Ecuador last December, Generex is finally gearing up to take on big pharma in the global non-injectable insulin arena and has picked Cardinal Health to help meet manufacturing demands.
28-Jun-2006 - Hyclone has unveiled a new single-use bioreactor at the BioLOGIC exhibition in Amsterdam which promises the same performance with traditional stainless steel bioreactors but with the benefits of single use in which all the contact parts are discarded after use.
28-Jun-2006 - Microsoft has awarded Pfizer with its Pharmaceutical and Life Sciences Innovation Award for its manufacturing management system which revolutionalises the scaling up and monitoring of active pharmaceutical ingredient (API) production, saving time and money.
28-Jun-2006 - Innovata is moving forward with its dry powder pulmonary insulin inhaler, which it claims has a formulation superior to Exubera, gearing up for Phase II clinical trials and anticipating a new partnership deal by the end of the year.
27-Jun-2006 - As the shortage of cartridges of its injectable diabetes drug Byetta reaches critical levels, Amylin Pharmaceuticals is seeking to expand manufacturing capacity and is exploring a nasal spray formulation of the medicine with drug delivery firm Nastech.
27-Jun-2006 - Tests have begun on a new bird flu vaccine that its US developer MedImmune hopes will prove more effective and provide several advantages over current injectable flu vaccines in the event of a bird flu pandemic.
27-Jun-2006 - Alpharma has asked one of the largest manufacturers of bulk active pharmaceutical ingredients (APIs) in China, Zhejiang Hisun Pharmaceutical, to help it double its capacity of making vancomycin.
27-Jun-2006 - Analytik Jena has started production of its first analytical apparatus to be made entirely in China representing a new venture for the company as it aims to advance into a market that has experienced unprecedented growth in the analytical instrument sector.
26-Jun-2006 - UK-based Malvern Instruments has revealed that its next-generation particle size analysis system is being used by French contract manufacturer Valois in the validation of its unique nasal spray device.
26-Jun-2006 - A toxic group of plant extracts has been found to protect animal tissue against the lack of blood that occurs in stroke giving rise to a new direction in the development of stroke treatment.
22-Jun-2006 - Millipore has unveiled new disposable Tangential Flow Filtration (TFF) assemblies that reduce validation efforts, increase process speed and mitigate risks.
22-Jun-2006 - Laboratory service provider, LabConnect has announced its intentions to expand into Central and Eastern Europe by adding Synevo Medicover Laboratory Services to its LabConnect network, becoming the first US-based central laboratory to do so.
22-Jun-2006 - The world's first drug made from a genetically engineered goat has been given the thumbs up in Europe after being initially rejected in February. The decision has reopened the door for "pharming," where transgenic animals or plants are used to make drugs.